Chávez-Velásquez M, Pons H, Medina M, Quiroz Y, Parra G, Herrera J
Centro de Medicina y Cirugía Experimental, Facultad de Medicina, Universidad del Zulia, Unidad de Diálisis y Trasplante Renal Hospital Universitario de Maracaibo, Venezuela.
Nefrologia. 2007;27(4):448-58.
Mycophenolate mofetil (MMF) is a purine synthesis inhibitor commonly used as immunosupresive agent in transplantation. Kidney grafts undergo more or less prolonged cold ischemia after harvesting which results in variable degrees of ischemia reperfusion injury. To determine whether the inhibition of early events of cellular infiltration may influence the severity of damage induced by ischemic acute renal failure, 45 Sprague Dawley rats were given MMF at a dose of 20mg/kg/day (MMF-rats) by gavage 2 days before (pre-MMF group, n=15) or after (post-MMF group, n=15) clamping the left renal artery for 40 minutes followed by rigt-sided nephrectomy. (control group, n=15) received vehicle. Serum Creatinine (Screat) was measured daily in all groups. On the 2nd post-ischemic day Screat was significantly lower (p=0.001) in pre-MMF group compared with post-MMF group and control group (4 +/- 2mg/dl post-MMF group vs 1.7 +/- 1.2 mg/dl pre-MMF group, control group 5+/-2, p< 0.05). Kidney biopsies shown that the histologic damage was 54 +/- 28% in post-MMF group vs 34+/- 22% in pre-MMF group and 61 +/- 25% in control group (pre-MMF vs post-MMF, p NS). On the 5th day post-ischemic, MMF-rats showed more severe tubulointerstitial necrosis (pre-MMF group: 17 +/- 20 %, post-MMF group: 33 +/- 27%) than controls (4 +/- 5%). The severity of ATN was significantly higher in post-MMF group compared with controls (p=0.01). Tubulointersticial T-lymphocyte (T CD 5) and monocyte (ED 1) infiltration evaluated on the 2nd post-ischemic day was less intense in group I (T CD5: 3 +/- 3, ED 1: 10 +/- 9, cel/mm2) compared to post-MMF group (T CD 5: 10 +/- 4, ED 1: 55 +/- 40) and to control group (T CD 5: 10+/- 4, ED 1: 64 +/- 46). However, on the 5th post-ischemia day, ED 1 infiltration was significantly higher in post-MMF group (24 +/- 18%) compared to pre-MMF group (5 +/- 5, p NS) and also in pre-MMF group vs control group (31 +/- 33, p< 0.05). Our results suggest that MMF given before a renal ischemic insult may reduce the severity of histologic damage resulting from ischemia reperfusion injury.
霉酚酸酯(MMF)是一种嘌呤合成抑制剂,在移植中常用作免疫抑制剂。肾移植在获取后会经历或多或少的长时间冷缺血,这会导致不同程度的缺血再灌注损伤。为了确定抑制细胞浸润的早期事件是否会影响缺血性急性肾衰竭所致损伤的严重程度,在夹闭左肾动脉40分钟并随后进行右侧肾切除术前2天(MMF预处理组,n = 15)或术后(MMF后处理组,n = 15),给45只Sprague Dawley大鼠经口灌胃给予剂量为20mg/kg/天的MMF。(对照组,n = 15)给予赋形剂。每天测量所有组的血清肌酐(Screat)。在缺血后第2天,MMF预处理组的Screat显著低于(p = 0.001)MMF后处理组和对照组(MMF后处理组为4±2mg/dl,MMF预处理组为1.7±1.2mg/dl,对照组为5±2,p <0.05)。肾活检显示,MMF后处理组的组织学损伤为54±28%,而MMF预处理组为34±22%,对照组为61±25%(MMF预处理组与MMF后处理组比较,p无统计学意义)。在缺血后第5天,MMF大鼠的肾小管间质坏死比对照组更严重(MMF预处理组:17±20%,MMF后处理组:33±27%)(对照组:4±5%)。与对照组相比,MMF后处理组急性肾小管坏死的严重程度显著更高(p = 0.01)。在缺血后第2天评估的肾小管间质T淋巴细胞(T CD 5)和单核细胞(ED 1)浸润,与MMF后处理组(T CD5:10±4,ED 1:55±40)和对照组(T CD 5:10±4,ED 1:64±46)相比,I组(T CD5:3±3,ED 1:10±9,细胞/mm2)的浸润程度较轻。然而,在缺血后第5天,与MMF预处理组(5±5,p无统计学意义)相比,MMF后处理组的ED 1浸润显著更高(24±18%),并且与对照组相比,MMF预处理组也更高(31±33,p <0.05)。我们的结果表明,在肾缺血损伤前给予MMF可能会降低缺血再灌注损伤所致组织学损伤的严重程度。